litlas
Log inCreate account

Michael R. Harrison

Active 1978–2025

203
Papers
32,781
Citations
111
h-index
200
i10-index

Citations

Citations per year for Michael R. Harrison1953: 1 citations1980: 1 citations1981: 12 citations1982: 20 citations1983: 15 citations1984: 31 citations1985: 36 citations1986: 24 citations1987: 20 citations1988: 40 citations1989: 40 citations1990: 72 citations1991: 92 citations1992: 72 citations1993: 85 citations1994: 86 citations1995: 69 citations1996: 109 citations1997: 120 citations1998: 101 citations1999: 74 citations2000: 137 citations2001: 110 citations2002: 70 citations2003: 197 citations2004: 142 citations2005: 165 citations2006: 125 citations2007: 176 citations2008: 164 citations2009: 143 citations2010: 116 citations2011: 164 citations2012: 128 citations2013: 94 citations2014: 149 citations2015: 138 citations2016: 162 citations2017: 147 citations2018: 165 citations2019: 595 citations2020: 617 citations2021: 669 citations2022: 535 citations2023: 358 citations2024: 591 citations2025: 237 citations2026: 8 citations1954–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,336 citing papers, 29.3% of this breakdownChina: 650 citing papers, 8.2% of this breakdownUnited Kingdom: 604 citing papers, 7.6% of this breakdownItaly: 409 citing papers, 5.1% of this breakdownGermany: 385 citing papers, 4.8% of this breakdownFrance: 360 citing papers, 4.5% of this breakdownCanada: 328 citing papers, 4.1% of this breakdownJapan: 247 citing papers, 3.1% of this breakdownSpain: 231 citing papers, 2.9% of this breakdownNetherlands: 225 citing papers, 2.8% of this breakdownAustralia: 209 citing papers, 2.6% of this breakdownBelgium: 198 citing papers, 2.5% of this breakdown
0%29.3%Other 22.5%

Institutions

Fields

  • Medicine80.3%
  • Biochemistry, Genetics and Molecular Biology11.1%
  • Engineering2.5%
  • Immunology and Microbiology2%
  • Neuroscience1.1%
  • Nursing0.6%
  • Other2.4%

Topics

  • Cancer Immunotherapy and Biomarkers6.6%
  • Congenital Diaphragmatic Hernia Studies5.2%
  • Renal cell carcinoma treatment4.8%
  • Bladder and Urothelial Cancer Treatments2.4%
  • Wound Healing and Treatments2.1%
  • Neonatal Respiratory Health Research2%
  • Other76.9%

Coauthors

All papers

Open in search
  1. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

    Authors: Robert J. Motzer, Brian I. Rini, David F. McDermott, Osvaldo Arén Frontera, Hans J. Hammers, Michael A. Carducci, Pamela Salman, Bernard Escudier, Benoit Beuselinck, Asim Amin, Camillo Porta, Saby George, Victoria Neiman, Sergio Bracarda, Scott S. Tykodi, Philippe Barthélémy, Raya Leibowitz‐Amit, Elizabeth R. Plimack, Sjoukje F. Oosting, Bruce G. Redman, Bohuslav Melichar, Thomas Powles, Paul Nathan, Stéphane Oudard, David Pook, Toni K. Choueiri, Frede Donskov, Marc‐Oliver Grimm, Howard Gurney, Daniel Y.C. Heng, Christian Kollmannsberger, Michael R. Harrison, Yoshihiko Tomita, Ignacio Durán, Viktor Grünwald, M. Brent McHenry, Sabeen Mekan, Nizar M. Tannir - The Lancet Oncology 2019 cited by 780

  2. Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial

    Authors: Evan Y. Yu, Daniel P. Petrylak, Peter H. O’Donnell, Jae‐Lyun Lee, Michiel S. van der Heijden, Yohann Loriot, Mark N. Stein, Andrea Necchi, Takahiro Kojima, Michael R. Harrison, Se Hoon Park, David I. Quinn, Elisabeth I. Heath, Jonathan E. Rosenberg, Joyce Steinberg, Shang-Ying Liang, Janet Trowbridge, Mary S. Campbell, Bradley A. McGregor, Arjun Vasant Balar - The Lancet Oncology 2021 cited by 267

  3. Endovascular Ultrasound Renal Denervation to Treat Hypertension

    Authors: Michel Azizi, Manish Saxena, Yale Wang, J. Stephen Jenkins, Chandan Devireddy, Florian Rader, Naomi D.L. Fisher, Roland E. Schmieder, Felix Mahfoud, Jason B. Lindsey, Kintur Sanghvi, Thomas M. Todoran, John Pacella, John M. Flack, Joost Daemen, Andrew Sharp, Philipp Lurz, Michael J. Bloch, Michael A. Weber, Melvin D. Lobo, Jan Basile, Lisa Claude, Helen Reeve-Stoffer, Candace K. McClure, Ajay J. Kirtane, RADIANCE II Investigators and Collaborators, Christopher M. Mullin, Candace K. McClure, Lisa Thackeray, Yongshi Wang, Glenn M. Chertow, Venita Chandra, Harold L. Dauerman, Thomas Kahan, Steven Ullery, Nirat Beohar, Ozgen Dogan, M Mokrzycki, Scott Mullaney, Björn Redfors, Huseng Vefali, Andreas Loening, Ron Zagoria, Nedaa Skeik, Richard Bae, Amy McMeans, JoAnne Goldman, Rose Peterson, Isabelle Tutor, Michael R. Harrison, Angel Penning, Janice P. Lea, Amanda Fiebach, Claudia Merlin, Suhail Dohad, Anne H. Tran, Kirin Bhatia, Piotr Sobieszczyk, Ian Halliday, Tay Munson, Steven B. Laster, Mathew Bunte, Anthony R Hart, Dana E. King, Jamie Hall, Courtney Krathen, Luot Lewis, Ashley Willitts, Anthony Awkar, Casey Palmer, Anna Tecklenburg, John Schindler, Matthew F. Muldoon, MaryJo Albright, Tracy L. Nicholson, Youseff Chami, Abdul Moiz Hafiz, Emily Starkey, Kristal Adams, Nelson L. Bernardo, Judith H. Veis, Hayder Hashim, Suman Singh, Donna Whitman, Rick Stouffer, Alan L. Hinderliter, Meghan Allen, Tatum Scholl, Pete Fong, James S. Gainer, Sherron Crook, Ellen Hatchcock, Debbie L. Cohen, Jay Giri, Taisei Kobayashi, Robin Neubauer, Suveeksha Naidu, Jai Radhakrishnan, Candido Batres, Suzanne Edwards and 154 more - JAMA 2023 cited by 180

  4. Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

    Authors: Robert J. Motzer, Brian I. Rini, David F. McDermott, Bruce G. Redman, Timothy M. Kuzel, Michael R. Harrison, Ulka N. Vaishampayan, Harry A. Drabkin, Saby George, Theodore F. Logan, Kim Margolin, Elizabeth R. Plimack, Alexandre Lambert, Ian M. Waxman, Hans J. Hammers - Journal of Clinical Oncology 2014 cited by 1,078

  5. Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial

    Authors: Scott S. Tykodi, Lucio Gordan, Robert Alter, Edward Arrowsmith, Michael R. Harrison, Ivor Percent, Rakesh Singal, Peter J. Van Veldhuizen, Daniel J. George, Thomas E. Hutson, Joshua Zhang, Jesús Zoco, Jennifer L. Johansen, Arash Rezazadeh Kalebasty - Journal for ImmunoTherapy of Cancer 2022 cited by 138

  6. Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

    Authors: Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, David F. McDermott, Robert J. Motzer, Abdallah Flaifel, Jean‐Christophe Pignon, Miriam Ficial, Osvaldo Arén Frontera, Saby George, Thomas Powles, Frede Donskov, Michael R. Harrison, Philippe Barthélémy, Scott S. Tykodi, Judit Kocsis, Alain Ravaud, Jerónimo Rafael Rodríguez‐Cid, Sumanta K. Pal, André M. Murad, Yuko Ishii, Shruti Shally Saggi, M. Brent McHenry, Brian I. Rini - Clinical Cancer Research 2020 cited by 242

  7. Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials

    Authors: Ajay J. Kirtane, Andrew Sharp, Felix Mahfoud, Naomi D.L. Fisher, Roland E. Schmieder, Joost Daemen, Melvin D. Lobo, Philipp Lurz, Jan Basile, Michael J. Bloch, Michael A. Weber, Manish Saxena, Yale Wang, Kintur Sanghvi, J. Stephen Jenkins, Chandan Devireddy, Florian Rader, Philippe Gosse, Marc Sapoval, Neil C. Barman, Lisa Claude, Dimitri Augustin, Lisa Thackeray, Christopher M. Mullin, Michel Azizi, RADIANCE Investigators and Collaborators, Candace K. McClure, Glenn M. Chertow, Venita Chandra, Harold L. Dauerman, Thomas Kahan, Steven Ullery, Nirat Beohar, Ozgen Dogan, M Mokrzycki, Scott Mullaney, Björn Redfors, Huseng Vefali, J. Dawn Abbott, Andreas Loening, Ron Zagoria, Nedaa Skeik, Richard Bae, Amy McMeans, JoAnne Goldman, Rose Peterson, Desmond Jay, Robert S. Schwartz, John P. Reilly, Micheal Cash, Isabelle Tutor, Michael R. Harrison, Shannon Williams, Maria Jarvis, Angel Penning, Janice P. Lea, Amanda Fiebach, Claudia Merlin, Bryan J. Wells, Suhail Dohad, Anne H. Tran, Kirin Bhatia, H. Mike Kim, Mohammad A Rashid, Ronald G. Victor, Piotr Sobieszczyk, Ian Halliday, Tay Munson, Laura Mauri, Alex Smith, Laura Aseltine, Jonathan S. Williams, Jason B. Lindsey, Steven B. Laster, Mathew Bunte, Anthony R Hart, Dana E. King, Jamie Hall, Josh Costello, Courtney Krathen, Luot Lewis, Andrew McElvarr, Ashley Willitts, Thomas M. Todoran, Eric R. Powers, Casey Palmer, Emily Hodskins, Vijay Paladugu, Anna Tecklenburg, John Schindler, John Pacella, Matthew F. Muldoon, MaryJo Albright, Tracy L. Nicholson, John M. Flack, Youseff Chami, Abdul Moiz Hafiz, Emily Starkey, Kristal Adams, Nelson L. Bernardo and 310 more - JAMA Cardiology 2023 cited by 82

  8. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial

    Authors: Alison Halliday, Michael R. Harrison, Elizabeth Hayter, Xiang-Ling Kong, Averil O. Mansfield, Joanna Marro, Hongchao Pan, Richárd Pető, John F. Potter, Kazem Rahimi, Angela Rau, Steven Robertson, Jonathan Y. Streifler, Dafydd J. Thomas - The Lancet 2010 cited by 925

  9. Atezolizumab: A PD-L1–Blocking Antibody for Bladder Cancer

    Authors: Brant A. Inman, Thomas A. Longo, Sundhar Ramalingam, Michael R. Harrison - Clinical Cancer Research 2016 cited by 244

  10. Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer

    Authors: Tracy L. Rose, Michael R. Harrison, Allison M. Deal, Sundhar Ramalingam, Young E. Whang, Blaine Brower, Mary Dunn, Chelsea K. Osterman, Hillary Heiling, Marc A. Bjurlin, Angela B. Smith, Matthew E. Nielsen, Hung‐Jui Tan, Eric Wallen, Michael Woods, Daniel J. George, Tian Zhang, Anthony Drier, William Y. Kim, Matthew I. Milowsky - Journal of Clinical Oncology 2021 cited by 135

  11. Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

    Authors: Toni K. Choueiri, Mayer Fishman, Bernard Escudier, David F. McDermott, Charles G. Drake, Harriet M. Kluger, Walter M. Stadler, José Luis Perez‐Gracia, Douglas G. McNeel, Brendan D. Curti, Michael R. Harrison, Elizabeth R. Plimack, Leonard L. Appleman, Lawrence Fong, Laurence Albigès, Lewis Cohen, Tina C. Young, Scott D. Chasalow, Petra Ross‐Macdonald, Shivani Srivastava, Maria Jure–Kunkel, John F. Kurland, Jason S. Simon, Mario Sznol - Clinical Cancer Research 2016 cited by 292

  12. LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

    Authors: Landon C. Brown, Matthew D. Tucker, Ramy Sedhom, Eric Schwartz, Jason Zhu, Chester Kao, Matthew Labriola, Rajan T. Gupta, Daniele Marin, Yuan Wu, Santosh Gupta, Tian Zhang, Michael R. Harrison, Daniel J. George, Ajjai Alva, Emmanuel S. Antonarakis, Andrew J. Armstrong - Journal for ImmunoTherapy of Cancer 2021 cited by 113

  13. Activation of a transient progenitor state in the epicardium is required for zebrafish heart regeneration

    Authors: Yu Xia, Sierra Duca, Björn Perder, Friederike Dündar, Paul Zumbo, Miaoyan Qiu, Jun Yao, Yingxi Cao, Michael R. Harrison, Lior Zangi, Doron Betel, Jingli Cao - Nature Communications 2022 cited by 52

  14. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program

    Authors: Michel Azizi, Andrew Sharp, Naomi D.L. Fisher, Michael A. Weber, Melvin D. Lobo, Joost Daemen, Philipp Lurz, Felix Mahfoud, Roland E. Schmieder, Jan Basile, Michael J. Bloch, Manish Saxena, Yale Wang, Kintur Sanghvi, J. Stephen Jenkins, Chandan Devireddy, Florian Rader, Philippe Gosse, Lisa Claude, Dimitri A. Augustin, Candace K. McClure, Ajay J. Kirtane, Yale Wang, Nedaa Skeik, Richard Bae, Amy McMeans, JoAnne Goldman, Rose Peterson, J. Stephen Jenkins, Isabelle Tutor, Michael R. Harrison, Angel Penning, Chandan Devireddy, Janice P. Lea, Amanda Fiebach, Claudia Merlin, Florian Rader, Suhail Dohad, Anne H. Tran, Kirin Bhatia, Naomi D.L. Fisher, Piotr Sobieszczyk, Ian Halliday, Tay Munson, Jason B. Lindsey, Steven B. Laster, Mathew Bunte, Anthony R Hart, Dana E. King, Jamie Hall, Kintur Sanghvi, Courtney Krathen, Luot Lewis, Ashley Willitts, Thomas M. Todoran, Jan Basile, Anthony Awkar, Casey Palmer, Anna Tecklenburg, John Schindler, John Pacella, Matthew F. Muldoon, MaryJo Albright, Tracy L. Nicholson, John M. Flack, Youseff Chami, Abdul Moiz Hafiz, Emily Starkey, Kristal Adams, Nelson L. Bernardo, Judith H. Veis, Hayder Hashim, Suman Singh, Donna Whitman, Rick Stouffer, Alan L. Hinderliter, Meghan Allen, Tatum Scholl, Pete Fong, James S. Gainer, Sherron Crook, Ellen Hatchcock, Debbie L. Cohen, Jay Giri, Taisei Kobayashi, Robin Neubauer, Suveeksha Naidu, Ajay J. Kirtane, Jai Radhakrishnan, Candido Batres, Suzanne Edwards, Matheen Khuddus, Suzanne Zentko, Abby Touchton, Marti Roberson, Michael J. Bloch, Abhilash Akinapelli, Lisa English, Bridget Neumann, Farrel Mendelsohn and 512 more - Circulation 2023 cited by 37

  15. Impedance sensing device enables early detection of pressure ulcers in vivo

    Authors: Sarah L. Swisher, Monica C. Lin, Amy Liao, Elisabeth J. Leeflang, Yasser Khan, Felippe J. Pavinatto, Kaylee Mann, Agne Naujokas, David M. Young, Shuvo Roy, Michael R. Harrison, Ana Claudia Arias, Vivek Subramanian, Michel M. Maharbiz - Nature Communications 2015 cited by 229

  16. CRISPR/Cas9-mediated precise genome modification by a long ssDNA template in zebrafish

    Authors: Haipeng Bai, Lijun Liu, Ke An, Xiaochan Lu, Michael R. Harrison, Yanqiu Zhao, Ruibin Yan, Zhijie Lu, Song Li, Shuo Lin, Fang Ting Liang, Wei Qin - BMC Genomics 2020 cited by 73

  17. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

    Authors: Talal El Zarif, Amin H. Nassar, Gregory R. Pond, Tony Zhuang, Viraj A. Master, Bassel Nazha, Scot A. Niglio, Nicholas I. Simon, Andrew W. Hahn, Curtis A. Pettaway, Shi‐Ming Tu, Noha Abdel‐Wahab, Maud Velev, Ronan Flippot, Sebastiano Buti, Marco Maruzzo, Arjun Mittra, Jinesh Gheeya, Yuanquan Yang, Pablo Alvarez Rodriguez, Daniel Castellano, Guillermo de Velasco, Giandomenico Roviello, Lorenzo Antonuzzo, Rana R. McKay, Bruno Vincenzi, Alessio Cortellini, Gavin Hui, Alexandra Drakaki, Michael Glover, Ali Raza Khaki, Edward El‐Am, Nabil Adra, Tarek H. Mouhieddine, Vaibhav G. Patel, A. Piedra, Angela Gernone, Nancy B. Davis, Harrison Matthews, Michael R. Harrison, Ravindran Kanesvaran, Giulia Claire Giudice, Pedro C. Barata, Alberto Farolfi, Jae‐Lyun Lee, Matthew I. Milowsky, Charlotte N. Stahlfeld, Leonard J. Appleman, Joseph W. Kim, Dory Freeman, Toni K. Choueiri, Philippe E. Spiess, Andrea Necchi, Andrea B. Apolo, Guru Sonpavde - JNCI Journal of the National Cancer Institute 2023 cited by 55

  18. Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia

    Authors: Jacques Jani, K. H. Nicolaides, Roberta L. Keller, Alexandra Benachi, Cleisson Fábio Andrioli Peralta, R. Favre, Óscar Moreno, Dick Tibboel, Shlomo Lipitz, A.J. Eggink, P. Vaast, Karel Allegaert, Michael R. Harrison, Jan Deprest, on behalf of the Antenatal‐CDH‐Registry Group - Ultrasound in Obstetrics and Gynecology 2007 cited by 625

  19. Chemokine-Guided Angiogenesis Directs Coronary Vasculature Formation in Zebrafish

    Authors: Michael R. Harrison, Jeroen Bussmann, Ying Huang, Long Zhao, Arthela Osorio, C. Geoffrey Burns, Caroline E. Burns, Henry M. Sucov, Arndt F. Siekmann, Ching‐Ling Lien - Developmental Cell 2015 cited by 162

  20. Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma

    Authors: Matthew D. Tucker, Landon C. Brown, Yu‐Wei Chen, Chester Kao, Nathan Hirshman, Emily N. Kinsey, Kristin Kathleen Ancell, Kathryn E. Beckermann, Nancy B. Davis, Renee McAlister, Kerry Schaffer, Andrew J. Armstrong, Michael R. Harrison, Daniel J. George, W. Kimryn Rathmell, Brian I. Rini, Tian Zhang - Biomarker Research 2021 cited by 42

  21. Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma

    Authors: Laure Hirsch, Nieves Martínez Chanzá, Subrina Farah, Wanling Xie, Ronan Flippot, David A. Braun, Nityam Rathi, Jonathan Thouvenin, Katharine A. Collier, Emmanuel Seront, Guillermo de Velasco, Hannah Dzimitrowicz, Benoit Beuselinck, Wenxin Xu, I. Alex Bowman, Elaine T. Lam, Bashar Abuqayas, Mehmet Asım Bilen, Andreas Varkaris, Yousef Zakharia, Michael R. Harrison, Amir Mortazavi, Philippe Barthélémy, Neeraj Agarwal, Rana R. McKay, Priscilla K. Brastianos, Katherine M. Krajewski, Laurence Albigès, Lauren C. Harshman, Toni K. Choueiri - JAMA Oncology 2021 cited by 95

  22. Late developing cardiac lymphatic vasculature supports adult zebrafish heart function and regeneration

    Authors: Michael R. Harrison, Xidi Feng, Guqin Mo, Antonio Aguayo, Jessi Villafuerte, Tyler Yoshida, Caroline A. Pearson, Stefan Schulte‐Merker, Ching‐Ling Lien - eLife 2019 cited by 92

  23. Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study

    Authors: Nieves Martínez Chanzá, Wanling Xie, Majd Issa, Hannah Dzimitrowicz, Abhishek Tripathi, Benoit Beuselinck, Elaine T. Lam, Yousef Zakharia, Rana R. McKay, Sumit Shah, Amir Mortazavi, Michael R. Harrison, Spyridon Sideris, Marina D. Kaymakcalan, Sarah Abou Alaiwi, Amin H. Nassar, Pier Vitale Nuzzo, Anis Hamid, Toni K. Choueiri, Lauren C. Harshman - Journal for ImmunoTherapy of Cancer 2020 cited by 34

  24. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

    Authors: Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam B. Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven Hancock, Michael R. Harrison, Won Kim, Christos E. Kyriakopoulos, Chad A. LaGrange, Elaine T. Lam, Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack, Bruce G. Redman, Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey A. Sosman, Mary A. Dwyer, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2017 cited by 580